Monopar Therapeutics Inc.(MNPR)
Biotech company.
1 Insight
Investment Insights
AI-generated insights about Monopar Therapeutics Inc. from various financial sources
Monday, October 6, 2025
Very Bearish
The speaker is bearish, stating the company's main drug is 'garbage' and considers the stock a 'shorter'.
Monday, October 6, 2025
Very Bearish
The speaker is bearish, stating the company's main drug is 'garbage' and considers the stock a 'shorter'.